These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2661684)

  • 41. Current status of the etiology of candidiasis in Mexico.
    Reyes-Montes MDR; Duarte-Escalante E; Martínez-Herrera E; Acosta-Altamirano G; Frías-De León MG
    Rev Iberoam Micol; 2017; 34(4):203-210. PubMed ID: 29032925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An unusual case of Candida tropicalis sepsis in a patient submitted to allogeneic bone marrow transplantation.
    Rosti G; Bandini G; Miggiano MC; Albertazzi L; Ricci P; Verlicchi F; Pileri S; Tura S
    Haematologica; 1990; 75(5):480-1. PubMed ID: 2097267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Candida infection in the severely burned patient--a successful treatment concept with liposomal amphotericin B].
    Pallua N; Schneider W
    Unfallchirurg; 1992 Dec; 95(12):641-3. PubMed ID: 1287849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
    Viviani MA; Tortorano AM; Malaspina C; Colledan M; Paone G; Rossi G; Bordone G; Pagano A
    Eur J Epidemiol; 1992 May; 8(3):433-6. PubMed ID: 1397207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Torulopsis candida, a new opportunistic pathogen.
    St-Germain G; Laverdière M
    J Clin Microbiol; 1986 Nov; 24(5):884-5. PubMed ID: 3533991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits.
    Chavanet P; Duong M; Buisson M; Hamel H; Dubois C; Bonnin A; Portier H
    J Antimicrob Chemother; 1997 Mar; 39(3):427-30. PubMed ID: 9096196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
    Walsh TJ; Lee JW; Roilides E; Pizzo PA
    Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes in epidemiology of opportunistic infections due to Candida].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serotyping of strains of Candida albicans isolated from children with acute lymphoid leukemia].
    Budak A; Trojanowska D; Pekacki A
    Med Dosw Mikrobiol; 1988; 40(3):161-6. PubMed ID: 3073280
    [No Abstract]   [Full Text] [Related]  

  • 54. [Current views on the pathogenesis of candidiasis].
    Piskozub E
    Postepy Hig Med Dosw; 1988; 42(6):682-93. PubMed ID: 3076659
    [No Abstract]   [Full Text] [Related]  

  • 55. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnosis and therapy of systemic candidiasis.
    Kozinn PJ; Taschdjian CL; Seelig MS; Caroline L; Teitler A
    Sabouraudia; 1969 Jun; 7(2):98-109. PubMed ID: 5346192
    [No Abstract]   [Full Text] [Related]  

  • 57. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Candida chorioretinitis: current therapeutic approach].
    Pournaras CJ; Issoua D; Saravelos S; Sunaric G
    Klin Monbl Augenheilkd; 1994 May; 204(5):334-6. PubMed ID: 8051865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candida tropicalis in human disease.
    Chai LY; Denning DW; Warn P
    Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe candidal infections in neutropenic patients.
    Swerdloff JN; Filler SG; Edwards JE
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S457-67. PubMed ID: 8274612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.